BioSpace News Archive

Job Trends

Oklahoma Proton Center Reopens After Equipment Upgrades

Oklahoma Proton Center, LLC reopened yesterday for treatment after a brief shutdown.

April 23, 2019
·
3 min read
Policy

Notice to the media - Government of Canada takes further steps to address the opioid crisis in British Columbia

The Honourable Ginette Petitpas Taylor, federal Minister of Health, will announce investments to address the opioids crisis in B.C.

April 23, 2019
·
1 min read
Deals

Halozyme To Host First Quarter 2019 Financial Results Webcast And Conference Call

Halozyme Therapeutics, Inc., a biotechnology company developing novel oncology and drug-delivery therapies, will webcast its Quarterly Update Conference Call for the first quarter 2019 on Tuesday, May 7 at 4:30 p.m. ET / 1:30 p.m. PT.

April 23, 2019
·
2 min read
Business

Accuray Reports Fiscal 2019 Third Quarter Results

Accuray Incorporated reported its financial results for the third quarter of fiscal 2019 ended March 31, 2019.

April 23, 2019
·
14 min read
Deals

Jazz Pharmaceuticals to Report 2019 First Quarter Financial Results on May 7, 2019

Jazz Pharmaceuticals plc announced that it will report its 2019 first quarter financial results on Tuesday, May 7, 2019, after the close of the financial markets.

April 23, 2019
·
2 min read
Deals

Alnylam to Webcast Conference Call Discussing First Quarter 2019 Financial Results

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced that it will report financial results for the first quarter ending March 31, 2019 on Wednesday, May 1, 2019, before the U.S. financial markets open.

April 23, 2019
·
2 min read
Business

Verastem Oncology Announces Amendment to Refinance Hercules Loan Facility

New Terms Provide for Lower Interest Rate and Longer Interest-Only Payment Period

April 23, 2019
·
3 min read
Drug Development

Sheppard Mullin Adds Life Sciences IP Duo in Del Mar

Firm Continues Expansion of IP Practice with Two Patent Prosecutors

April 23, 2019
·
4 min read
Deals

Edwards Lifesciences Reports First Quarter Results - April 23, 2019

Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, reported financial results for the quarter ended March 31, 2019.

April 23, 2019
·
21 min read
Genetown

AVEO Oncology Announces $2M Milestone Payment From EUSA Pharma Related To Commercialization of FOTIVDA® in Spain

AVEO Oncology announced the triggering of a $2 million milestone payment to AVEO from EUSA Pharma.

April 23, 2019
·
8 min read